HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Han-mei Xu Selected Research

ethyldeshydroxysparsomycin (EdSm)

9/2012RGD-modified endostatin fragments showed an antitumor effect through antiangiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Han-mei Xu Research Topics

Disease

1Neoplasms (Cancer)
09/2012

Drug/Important Bio-Agent (IBA)

1arginyl-glycyl-aspartic acidIBA
09/2012
1ethyldeshydroxysparsomycin (EdSm)IBA
09/2012
1Amino AcidsFDA Link
09/2012
1Peptides (Polypeptides)IBA
09/2012
1EndostatinsIBA
09/2012